• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铅对体内和体外红细胞胆色素原脱氨酶活性的影响。

Effect of lead on the activity of erythrocyte porphobilinogen deaminase in vivo and in vitro.

作者信息

Tomokuni K, Ichiba M

机构信息

Department of Community Health Science, Saga Medical School, Japan.

出版信息

Toxicol Lett. 1990 Feb;50(2-3):137-42. doi: 10.1016/0378-4274(90)90003-5.

DOI:10.1016/0378-4274(90)90003-5
PMID:2309232
Abstract

The effect of lead on the activity of erythrocyte porphobilinogen deaminase (PBGD) in vivo and in vitro was investigated using blood specimens obtained from controls and lead-exposed workers. When lead nitrate was added to the incubation mixture at a final concentration of 10(-4) M, 83% inhibition of erythrocyte PBGD activity was found. However, in workers occupationally exposed to lead, no inhibition of erythrocyte PBGD activity was detected. This finding indicates that the erythrocyte PBGD test is not useful for evaluating exposure to lead in workers. In addition, the in vitro study confirmed that mercuric chloride strongly inhibits erythrocyte PBGD activity.

摘要

利用从对照组和铅暴露工人采集的血样,研究了铅在体内和体外对红细胞胆色素原脱氨酶(PBGD)活性的影响。当向孵育混合物中添加终浓度为10⁻⁴ M的硝酸铅时,发现红细胞PBGD活性受到83%的抑制。然而,在职业性铅暴露工人中,未检测到红细胞PBGD活性受到抑制。这一发现表明,红细胞PBGD检测对于评估工人的铅暴露情况并无用处。此外,体外研究证实,氯化汞可强烈抑制红细胞PBGD活性。

相似文献

1
Effect of lead on the activity of erythrocyte porphobilinogen deaminase in vivo and in vitro.铅对体内和体外红细胞胆色素原脱氨酶活性的影响。
Toxicol Lett. 1990 Feb;50(2-3):137-42. doi: 10.1016/0378-4274(90)90003-5.
2
Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].胆色素原脱氨酶活性是人类血红素生物合成中的一种次级调控机制吗?[会议论文集]
Biochem Soc Trans. 1977;5(5):1466-8. doi: 10.1042/bst0051466.
3
Determination of erythrocyte porphobilinogen deaminase activity using porphobilinogen as substrate.以胆色素原作为底物测定红细胞胆色素原脱氨酶活性。
Clin Chim Acta. 1987 Sep 30;168(2):257-8. doi: 10.1016/0009-8981(87)90296-8.
4
Isolation of a factor that protects against lead inhibition of hepatic and erythrocytic uroporphyrinogen I synthetase activity.
Life Sci. 1976 Oct 15;19(8):1225-34. doi: 10.1016/0024-3205(76)90258-7.
5
Uroporphyrinogen-I-synthetase activity in red blood cells of lead-exposed workers.铅接触工人红细胞中的尿卟啉原-I-合成酶活性。
Acta Med Acad Sci Hung. 1982;39(1-2):95-100.
6
Erythrocyte porphobilinogen deaminase activity in porphyria cutanea tarda.
Clin Chem. 1990 Oct;36(10):1779-83.
7
Determination of porphobilinogen deaminase activity in human erythrocytes: pertinent factors in obtaining optimal conditions for measurements.
Scand J Clin Lab Invest. 2000 Nov;60(7):627-34. doi: 10.1080/003655100448383.
8
Pteridine regulation of inhibition of hepatic uroporphyrinogen L synthetase activity by lead chloride.
Mol Pharmacol. 1977 Nov;13(6):1126-35.
9
Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation.改良红细胞尿卟啉原I合酶测定及其临床解读。
Clin Chem. 1978 Oct;24(10):1751-4.
10
Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography.
Clin Chim Acta. 1987 Jan 15;162(1):61-8. doi: 10.1016/0009-8981(87)90233-6.